Search results
Barstool Sports founder Dave Portnoy says he beat cancer
New York Daily News· 3 days agoBarstool Sports founder Dave Portnoy revealed this week he had cancer, but is going to be fine. “I...
Dave Portnoy Breaks His Silence on Cancer Diagnosis, Treatment
Men's Journal· 3 days agoAfter revealing his diagnosis, Portnoy explained his prognosis on his podcast. After Dave Portnoy...
Controversial Sports Analyst Stuns Fans with Shocking Cancer Diagnosis
Athlon Sports· 3 days agoFew members of the sports media world are more polarizing than Barstool Sports founder Dave Portnoy,...
A&M’s all-time leading rusher Darren Lewis dies at 55 after battle with cancer
The Bryan-College Station Eagle· 2 days agoFormer Texas A&M running back Darren Lewis, the school’s all-time leading rusher, has died after a...
Barstool Sports’ Dave Portnoy reveals cancer diagnosis
The Patriot-News· 4 days agoBarstool Sports founder and owner Dave Portnoy revealed Wednesday that he had cancer. “That sounds...
Be sun savvy, protect yourself from skin cancer
Medical Xpress· 4 days agoUltraviolet rays from the sun can cause skin damage in as little as 15 minutes. Prolonged exposure and damage can lead to various forms of skin cancer,...
Jack Smith sends warning message to Paralympic wheelchair rugby rivals
PA Media: Sport via Yahoo Sports· 16 hours agoAny one of seven teams could pick up a medal easily.” Smith’s own story is a remarkable one. Having...
Odynophagia Treatments Based on Underlying Causes
Verywell Health via Yahoo News· 5 days ago...drugs (NSAIDs) such as Aleve (naproxen) or Advil and Motrin (ibuprofen) Throat cancer, esophageal cancer, or other tumors in the surrounding areas...
The best thing I ate this week: Breakfast Burrito at Theo's Java Cafe in Rock Island
Quad-City Times· 5 days agoTheo's Java Cafe is a great place to relax, read or study. Grab a breakfast burrito while you're...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...